Sheriar G. Hormuzdi,2,
,
Jeffrey A. Meganck,3 and
Paul Bornstein2,4*
Departments of Orthopaedic Surgery, and Cell and Developmental Biology and Unit for Laboratory Animal Medicine,1 Mechanical Engineering, University of Michigan, Ann Arbor, Michigan 48109,3 Departments of Biochemistry,2 Medicine, University of Washington, Seattle, Washington 981954
Received 6 January 2005/ Returned for modification 4 March 2005/ Accepted 27 March 2005
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
The TSP family consists of five members and can be divided into two groups. TSP1 and TSP2 are trimers with a chain molecular mass of 145 kDa, whereas TSPs 3 to 5 are pentamers with a subunit mass of
110 kDa. TSPs 3 to 5 differ from TSPs 1 and 2 in that they lack the procollagen domain and type I repeats of the trimeric proteins and contain four rather than three type II (epidermal growth factor-like) repeats (1, 6).
The expression of TSP3 mRNA has been studied in the developing mouse (17, 25), chicken (28), Xenopus laevis (30), and adult human tissues (2). Expression was detected in the perichondrium and in the proliferating zone of the growth plate in long bones and vertebrae after day 15, in the dentate gyrus, accessory olfactory bulbs, hippocampus, and choroid plexus of the brain after day 17, and in the terminal bronchi and alveoli of the lung after day 17. Qabar et al. (26), using midline sagittal sections of whole embryos, reported expression in the forming musculature of the body wall and intestine, in the sternum and vertebrae, and in the brain and lung. Qabar et al. (25) also identified TSP3 protein by immunohistochemistry with an antipeptide antibody in extraembryonic membranes, developing cartilage, several tissues of the eye, dorsal root ganglia, peripheral nerve, and brain of mouse embryos. However, the specificity of the antibody that was used in this study is questionable, since in another study it stained all tissues in some sections indiscriminantly (26). In the chicken, TSP3 mRNA was expressed in embryonic cartilage and in neurons that are actively extending processes (28), and in Xenopus embryos TSP3 mRNA was detected in the notocord, floor plate, sensorial layer of the ectoderm, and sensory epithelia (30).
Pentameric TSPs, including TSP3, form
-helical coiled-coil domains in which the axial channel or pore is lined by hydrophobic amino acids (12, 22, 24). In the case of TSP5/COMP this axial pore is capable of binding physiologically relevant hydrophobic molecules such as vitamin D and all-trans retinol with appropriate affinities (14), and this property is likely to extend to TSP3. More recently, the crystal structure of TSP5/COMP complexed with vitamin D3 has been solved and shows the presence of two D3 molecules arranged head-to-head in the channel (23). Despite these studies and information concerning the spatial and temporal expression of TSP3, there is presently no good indication of the function of the protein in vivo. Accordingly, we performed a targeted disruption of the Thbs3 gene in mice. Interestingly, despite normal skeletal patterning in utero, TSP3-null mice have an altered pattern of postnatal bone modeling. While wild-type and TSP3-null mice have similar bone mass, TSP3-null bone is geometrically distributed farther from a central axis, resulting in enhanced mechanical function. TSP3-null mice also have altered endochondral bone formation, with accelerated ossification of the femoral head.
| MATERIALS AND METHODS |
|---|
|
|
|---|
|
600-bp BstXI-EcoRI genomic probe was located 3' to the Thbs3 sequence present in the targeting vector (Fig. 1) and detected 17.9- and 4.5-kb fragments derived from the wild-type and targeted alleles, respectively (Fig. 1B). To avoid poor germ line transmission due to karyotypic abnormalities in ES cells (21), we determined the karyotypes of correctly targeted clones and selected those with a normal complement of chromosomes for blastocyst injection. Chimeric mice generated from successfully injected blastocysts were bred to produce homozygous Thbs3/ mice. Southern blot analysis of tail DNA, restricted with EcoRI and EcoRV and hybridized with the BstXI-EcoRI genomic probe, was used to determine the genotype of mice. This procedure detected the 2.9- and 4.5-kb fragments derived from the wild-type and mutant alleles, respectively (Fig. 1C).
Northern blot analysis. RNA extracted from the lungs of 40-day-old wild-type and TSP3/ littermates by the guanidium thiocyanate method (8) was subjected to Northern blot analysis. RNA was separated on a 1.2% agarose gel containing 2.2 M formaldehyde and, after transfer to Zetabind membrane (Cuno Inc., Meriden, CT), was hybridized with a 1.1-kb 32P-labeled Thbs3 cDNA probe that extended from the start of translation to an XhoI site in the type II repeats (4). The same blot was also probed with a mouse ß-actin fragment obtained from Ambion Inc.
Histological analysis. Sections of lung, liver, kidney, stomach, small and large intestine, cerebrum, cerebellum, long bone (femur and tibia), pancreas, spleen, heart, thymus, colon, and spine were fixed in 10% formalin and embedded in paraffin. Sections were stained with hematoxylin and eosin and examined by light microscopy.
Skeletal development. To examine primary skeletal growth and development in utero, eight wild-type and seven TSP2-null embryos were harvested from two wild-type and TSP3-null females, respectively, at day 18 postcoitus. The embryos were fixed in 70% ethanol and stained with Alizarin red S and Alcian blue. To examine postnatal skeletal development, femurs were harvested from both male and female TSP3-null and wild-type mice at 9 and 15 weeks. Femurs to be used for microcomputed tomography and four-point bending studies were stored in phosphate-buffered saline at 4°C prior to testing. Femurs to be used for histological analysis were stored in 10% neutral buffered formalin at 4°C. Histological analysis was performed on TSP3-null specimens at each time point by decalcifying specimens, embedding in paraffin, sectioning with a microtome, and staining with hematoxylin and eosin or Safranin-O. In some cases, femurs were left undecalcified and embedded in plastic, thin sectioned and stained using von Kossa's method or toluidene blue.
Skeletal geometry. Geometrical properties of the harvested femurs were determined using microcomputed tomography (microCT). Femurs were scanned at 18-µm voxel resolution (GE Medical Systems) using the Parker method, and three-dimensional images were reconstructed. Diaphyseal bone length was measured directly on the resulting reconstructed image from the lesser trochanter to the most proximal point of the distal epiphyseal growth plate. These images were then thresholded using a previously defined method (19). The midcortical geometrical properties were determined in a 3-mm segment of the middiaphysis using custom software. The center plane of this 3-mm segment was defined as the midpoint between the most lateral point of the lesser trochanter and the most proximal point of the distal epiphyseal growth plate (15). The geometrical properties that were analyzed were cross-sectional area, cortical thickness, moment of inertia, and endocortical and periosteal radii. The endocortical radius extends from the centroid of the section to the endocortical surface and the periosteal radius is defined as the distance from the centroid to the periosteal surface. Trabecular bone parameters in a 1-mm3 region proximal to the distal femoral growth plate were evaluated utilizing the stereology function of GE Medical Systems Microview software.
To assess femoral head development, coronal planes from three-dimensional images of each specimen were grouped into one of three categories: homogenous gray density without trabeculation, partial trabeculation, or fully trabeculated femoral head, with an absence of the growth plate. All subjective analyses were preformed by two blinded, independent viewers.
Mechanical testing of femurs. Femurs were loaded to failure in four-point bending at 0.5 mm/s in the anterior-posterior direction using a servohydraulic testing machine (810 Material Test System; Eden Prairie, MN). Regions loaded in four-point bending corresponded to those measured by microCT, where the anterior surface was in compression and the posterior surface was in tension. Crosshead displacement was monitored using an external linear variable displacement transducer (Lucas Control Systems; Hampton, VA) and load data were collected with a 50 lb load cell (Sensotec; Columbus, OH). Load-displacement curves were analyzed for whole bone stiffness, yield load, failure load, yield displacement, and failure displacement.
Statistical analysis. Results were analyzed for statistical significance within an age and gender group using two-tailed Student's t test, assuming equal variance. Results were considered to be statistically significant if P is <0.05.
| RESULTS |
|---|
|
|
|---|
Southern analysis of genomic DNA in ES cells and mice clearly documented the insertion of the neomycin gene in the mutant Thbs3 allele (Fig. 1B and C). This insertion introduces an in-frame stop codon 5' to the first loxP element and is expected to create a null Thbs3 allele. This prediction was supported by Northern analysis of RNA isolated from lungs of homozygous mutant mice and their wild-type litter mates (Fig. 1D). Whereas abundant transcript was detected in the lungs of wild-type mice (Fig. 1D, lane 2), the lungs of homozygous mutant mice lacked detectable Thbs3 transcript (Fig. 1D, lane1). A similar result was obtained by Northern analysis of RNA derived from brain (data not shown).
Characterization of TSP3-null mice. Physical examination of homozygous mutant mice indicated that there were no obvious anatomical differences from their wild-type littermates. Thbs3-null mice developed normally and were fertile. An extensive histological examination was undertaken to determine whether tissue structure was also normal at the light microscopic level. Accordingly, microscopic evaluation of many adult tissues was conducted, including those that had been shown previously to express significant amounts of TSP3 mRNA or protein, e.g., lung, cartilage, brain and small intestine. However, these studies failed to reveal significant abnormalities in Thbs3-null mice (results not shown).
Skeletal development. Alcian blue and Alizarin red S staining was used to evaluate distribution of cartilage and bone in day 18 whole embryos. There was no notable difference in skeletal patterning between TSP3-null and wild-type mice (data not shown). Interestingly, both male (22.3 versus 24.7 g) and female (18.7 versus 20.2 g) TSP3-null mice were significantly heavier at 9 week, but this difference was no longer apparent at 15 week.
To assess postnatal skeletal development in more detail, we harvested femurs from wild-type and TSP3-null mice at various ages and from both genders. Mid-cortical femoral geometric analyses were performed, and distal femoral trabecular bone was evaluated by microCT, as previously described (15). Moments of inertia were significantly higher for TSP3-null mice in comparison to wild-type mice for males at both 9 and 15 weeks and for females at 9 weeks of age (Table 1.). The moment of inertia quantifies geometrical distribution of bone about a central axis, so an increase can be related to either thicker bone (cortical thickness) or an equivalent thickness of bone located further from the central axis. TSP3-null mice did not show an increase in cortical thickness, but had greater periosteal and endocortical diameters in comparison to the wild-type mice for males at 9 and 15 weeks and for female mice at 9 weeks of age (Table 1). In older male mice these measurements also reverted to normal (data not shown). Additionally, the 9-week-old TSP3-null male mice had an increase in cortical area. Upon analysis of the distal femurs, there were no differences in trabecular bone volume fraction (data not shown).
|
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
An additional possible explanation for both the increase in cross-sectional area and the alteration in endochondral ossification in long bones of TSP3-null mice is the early increase in body weight of these mice. Kodama et al. (18) have shown an increase in periosteal perimeter, cortical area, and periosteal mineral apposition rate in tibiae from C57BL/6 mice when the animals were subjected to higher mechanical loads. Mechanical factors may also contribute to ossification of femoral head cartilage. Thus, the formation of trabecular bone reinforces long bones that are subjected to increased loading resulting from increased body weight (13) and an increase in shear stress is linked to the transformation of cartilage into trabecular bone (3). Similarly, the early increase in body weight of TSP3-null mice may cause an increase in shear stress and thereby accelerate the formation of trabecular bone.
Although increased body weight may contribute to the skeletal phenotype, we believe it is unlikely to represent the sole cause. Appreciable differences in bone geometry and in femoral head ossification persist in 15-week males, despite the absence of statistically significant differences in body weight. Given the presence of TSP3 in cartilage and bone, we postulate that TSP3 is playing a role locally in regulating postnatal bone modeling and endochondral ossification. In view of the broad distribution of TSP3 during development, it is likely that other abnormalities will be found as these mice are studied further, and such new findings could help to determine whether increased body mass is a primary or secondary factor in establishing the phenotype of TSP3-null mice. In particular we anticipate that as we examine secondary centers that ossify much earlier than the femoral head, we will see a similar pattern of accelerated ossification in TSP3-null mice.
The mechanism by which TSP3 might regulate bone maturation and ossification of calcified cartilage is presently unknown. Guo et al. (14) have shown that retinoic acid and vitamin D3 can bind to the axial pore in TSP5. Both of these factors play a role in endochondral ossification, so a disruption of a similar interaction with TSP3 is a possible cause of the phenotypic abnormalities in TSP3-null mice. Another basis for the changes in bone in TSP3-null mice is the possible interaction of TSP3 with type IX collagen. Type IX collagen is present in cartilage (11) and is known to interact with the C terminus of TSP5 (16). Alterations in this interaction have been implicated as possible causes of pseudoachondroplasia and multiple epiphyseal dysplasia (16, 27). Alternatively, TSP3 could function by interacting with various cell types during the process of ossification, or the protein could play a direct structural role.
Since TSP3 appears to be required for proper progression of postnatal endochondral ossification, it is surprising that its absence does not have an impact on prenatal skeletal patterning, as judged by Alcian blue/Alizarin red S staining. Iruela-Arispe et al. have previously used in situ hybridization to show that TSP3 is present in murine fetal cartilage as early as 15 days postconception (17). Similarly, Svensson et al. did not report any phenotypic alterations in COMP/TSP5-deficient mice, despite the prevalence of COMP in growth cartilage (26). When one considers the homology in structure and the overlapping expression patterns between TSP3 and COMP, it is possible that COMP and TSP3 play compensatory roles in reducing the severity of the phenotypes of TSP3-null and COMP-null mice, respectively. However, we do not think that overlapping functions explain the mild phenotypes of TSP3-null and COMP-null mice. We have generated double TSP3/TSP5 knockout mice, and preliminary analysis has not revealed an increase in severity of the phenotype in these mice. For example, both TSP3-null and double knockout mice show similar increases in bone geometric and mechanical properties relative to wild-type mice (K. Hankenson and P. Bornstein, unpublished results).
In conclusion, this study demonstrates that TSP3 regulates postnatal skeletal maturation. At 9 weeks, TSP3-null femurs show an increase in mid-cortical moment of inertia which in turn results in enhanced bending strength of the bones. Most significantly, TSP3 affects the rate of endochondral ossification. Thus, in the absence of TSP3, there is accelerated ossification of femoral head calcified cartilage.
| ACKNOWLEDGMENTS |
|---|
We thank Carol Ware and the Nathan Shock Center for Aging for assistance with blastocyst injections and generation of chimeric mice, Bernard Buetow for expertise in mouse histopathology, Janet Hall for expertise in statistical analysis, and Jennifer Tullis, Emily Stainbrook, Ken Kozloff, Suzanne Volkman, David Fischer, Rochelle Taylor, John Baker, and Daniel Meram for skillful technical assistance.
| FOOTNOTES |
|---|
These two authors contributed equally. ![]()
Present address: University Hospital of Neurology, Heidelberg, Germany. ![]()
| REFERENCES |
|---|
|
|
|---|
2. Adolph, K. W. 1999. Relative abundance of thrombospondin 2 and thrombospondin 3 mRNAs in human tissues. Biochem. Biophys. Res. Commun. 258:792-796.[CrossRef][Medline]
3. Beaupre, G. S., S. S. Stevens, and D. R. Carter. 2000. Mechanobiology in the development, maintenance, and degeneration of articular cartilage. J. Rehabil. Res. Dev. 37:145-151.[Medline]
4. Bornstein, P., S. Devarayalu, S. Edelhoff, and C. M. Disteche. 1993. Isolation and characterization of the mouse thrombospondin 3 (Thbs3) gene. Genomics 15:607-613.[CrossRef][Medline]
5. Bornstein, P., C. E. McKinney, M. E. LaMarca, S. Winfield, T. Shingu, S. Devarayalu, H. L. Vos, and E. I. Ginns. 1995. Metaxin, a gene contiguous to both thrombospondin 3 and glucocerebrosidase, is required for embryonic development in the mouse: implications for Gaucher disease. Proc. Natl. Acad. Sci. USA 92:4547-4551.
6. Bornstein, P., and E. H. Sage. 1994. Thrombospondins. Methods Enzymol. 245:62-85.[Medline]
7. Brodt, M. D., C. B. Ellis, and M. J. Silva. 1999. Growing C57BL/6 mice increase whole bone mechanical properties by increasing geometric and material properties. J. Bone Miner. Res. 14:2159-2166.[CrossRef][Medline]
8. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.[Medline]
9. Collins, M., and P. Bornstein. 1996. SP1-binding elements, within the common metaxin-thrombospondin 3 intergenic region, participate in the regulation of the metaxin gene. Nucleic Acids Res. 24:3661-3669.
10. Collins, M., P. Rojnuckarin, Y. H. Zhu, and P. Bornstein. 1998. A far upstream, cell type-specific enhancer of the mouse thrombospondin 3 gene is located within intron 6 of the adjacent metaxin gene. J. Biol. Chem. 273:21816-21824.
11. Cremer, M. A., E. F. Rosloniec, and A. H. Kang. 1998. The cartilage collagens: a review of their structure, organization, and role in the pathogenesis of experimental arthritis in animals and in human rheumatic disease. J. Mol. Med. 76:275-288.[CrossRef][Medline]
12. Engel, J. 2004. Role of oligomerization domains in thrombospondins and other extracellular matrix proteins. Int. J. Biochem. Cell Biol. 36:997-1004.[CrossRef][Medline]
13. Felisbino, S. L., and H. F. Carvalho. 2001. Growth cartilage calcification and formation of bone trabeculae are late and dissociated events in the endochondral ossification of Rana catesbeiana. Cell Tissue Res. 306:319-323.[CrossRef][Medline]
14. Guo, Y., D. Bozic, V. N. Malashkevich, R. A. Kammerer, T. Schulthess, and J. Engel. 1998. All-trans retinol, vitamin D and other hydrophobic compounds bind in the axial pore of the five-stranded coiled-coil domain of cartilage oligomeric matrix protein. EMBO J. 17:5265-5272.[CrossRef][Medline]
15. Hankenson, K. D., S. D. Bain, T. R. Kyriakides, E. A. Smith, S. A. Goldstein, and P. Bornstein. 2000. Increased marrow-derived osteoprogenitor cells and endosteal bone formation in mice lacking thrombospondin 2. J. Bone Miner. Res. 15:851-862.[CrossRef][Medline]
16. Holden, P., R. S. Meadows, K. L. Chapman, M. E. Grant, K. E. Kadler, and M. D. Briggs. 2001. Cartilage oligomeric matrix protein interacts with type IX collagen, and disruptions to these interactions identify a pathogenetic mechanism in a bone dysplasia family. J. Biol. Chem. 276:6046-6055.
17. Iruela-Arispe, M. L., D. J. Liska, E. H. Sage, and P. Bornstein. 1993. Differential expression of thrombospondin 1, 2, and 3 during murine development. Dev. Dyn. 197:40-56.[Medline]
18. Kodama, Y., Y. Umemura, S. Nagasawa, W. G. Beamer, L. R. Donahue, C. R. Rosen, D. J. Baylink, and J. R. Farley. 2000. Exercise and mechanical loading increase periosteal bone formation and whole bone strength in C57BL/6J mice but not in C3H/Hej mice. Calcif. Tissue Int. 66:298-306.[CrossRef][Medline]
19. Kuhn, J. L., S. A. Goldstein, L. A. Feldkamp, R. W. Goulet, and G. Jesion. 1990. Evaluation of a microcomputed tomography system to study trabecular bone structure. J. Orthop. Res. 8:833-842.[CrossRef][Medline]
20. Laird, P. W., A. Zijderveld, K. Linders, M. A. Rudnicki, R. Jaenisch, and A. Berns. 1991. Simplified mammalian DNA isolation procedure. Nucleic Acids Res. 19:4293.
21. Liu, X., H. Wu, J. Loring, S. Hormuzdi, C. M. Disteche, P. Bornstein, and R. Jaenisch. 1997. Trisomy eight in ES cells is a common potential problem in gene targeting and interferes with germ line transmission. Dev. Dyn. 209:85-91.[CrossRef][Medline]
22. Malashkevich, V. N., R. A. Kammerer, V. P. Efimov, T. Schulthess, and J. Engel. 1996. The crystal structure of a five-stranded coiled coil in COMP: a prototype ion channel? Science 274:761-765.
23. Ozbek, S., J. Engel, and J. Stetefeld. 2002. Storage function of cartilage oligomeric matrix protein: the crystal structure of the coiled-coil domain in complex with vitamin D(3). EMBO J. 21:5960-5968.[CrossRef][Medline]
24. Qabar, A., L. Derick, J. Lawler, and V. Dixit. 1995. Thrombospondin 3 is a pentameric molecule held together by interchain disulfide linkage involving two cysteine residues. J. Biol. Chem. 270:12725-12729.
25. Qabar, A. N., Z. Lin, F. W. Wolf, K. S. O'Shea, J. Lawler, and V. M. Dixit. 1994. Thrombospondin 3 is a developmentally regulated heparin binding protein. J. Biol. Chem. 269:1262-1269.
26. Svensson, L., A. Aszodi, D. Heinegard, E. B. Hunziker, F. P. Reinholt, R. Fassler, and A. Oldberg. 2002. Cartilage oligomeric matrix protein-deficient mice have normal skeletal development. Mol. Cell. Biol. 22:4366-4371.
27. Thur, J., K. Rosenberg, D. P. Nitsche, T. Pihlajamaa, L. Ala-Kokko, D. Heinegard, M. Paulsson, and P. Maurer. 2001. Mutations in cartilage oligomeric matrix protein causing pseudoachondroplasia and multiple epiphyseal dysplasia affect binding of calcium and collagen I, II, and IX. J. Biol. Chem. 276:6083-6092.
28. Tucker, R. P., C. Hagios, R. Chiquet-Ehrismann, and J. Lawler. 1997. In situ localization of thrombospondin-1 and thrombospondin-3 transcripts in the avian embryo. Dev. Dyn. 208:326-337.[CrossRef][Medline]
29. Turner, C. H., Y. F. Hsieh, R. Muller, M. L. Bouxsein, D. J. Baylink, C. J. Rosen, M. D. Grynpas, L. R. Donahue, and W. G. Beamer. 2000. Genetic regulation of cortical and trabecular bone strength and microstructure in inbred strains of mice. J. Bone Miner. Res. 15:1126-1131.[CrossRef][Medline]
30. Urry, L. A., C. A. Whittaker, M. Duquette, J. Lawler, and D. W. DeSimone. 1998. Thrombospondins in early Xenopus embryos: dynamic patterns of expression suggest diverse roles in nervous system, notochord, and muscle development. Dev. Dyn. 211:390-407.[CrossRef][Medline]
31. Vos, H. L., S. Devarayalu, Y. de Vries, and P. Bornstein. 1992. Thrombospondin 3 (Thbs3), a new member of the thrombospondin gene family. J. Biol. Chem. 267:12192-12196.
32. Vos, H. L., M. Mockensturm-Wilson, P. M. Rood, A. M. Maas, T. Duhig, S. J. Gendler, and P. Bornstein. 1995. A tightly organized, conserved gene cluster on mouse chromosome 3 (E3-F1). Mamm. Genome 6:820-822.[CrossRef][Medline]
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|